PRTH

NASDAQ · Financial Services

Priority Technology Holdings

Small-Cap Stocks Stocks Under $10 Bank & Financial Stocks

$5.75

-0.20 (-3.36%)

PRTH News1 articles

Pfizer Gains on FDA Priority Review for Padcev as Pipeline Pivots Post-COVID

Pfizer shares advanced after the FDA granted priority review for its Padcev bladder cancer therapy, setting an August decision. Investors await Q1 results to gauge progress in oncology and obesity drugs against fading COVID sales.

Earnings Apr 20